Biopharmaceutics Classification System

The Biopharmaceutics Classification System (BCS) is a system to differentiate drugs on the basis of their solubility and permeability.

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

The Biopharmaceutics Classification System (BCS) is a system to differentiate drugs on the basis of their solubility and permeability. This system restricts the prediction using the parameters solubility and intestinal permeability. The solubility classification is based on a United States Pharmacopoeia (USP) aperture.

The intestinal permeability classification is based on a comparison to the intravenous injection. All those factors are highly important because 85% of the most sold drugs in the United States and Europe are orally administered.

Definitions

The drugs are classified in BCS on the basis of solubility and permeability. Solubility class boundaries are based on the highest dose strength of an immediate release product. A drug is considered highly soluble when the highest dose strength is soluble in 250 ml or less of aqueous media over the pH range of 1 to 6.8.

The volume estimate of 250 ml is derived from typical bioequivalence study protocols that prescribe administration of a drug product to fasting human volunteers with a glass of water. Permeability class boundaries are based indirectly on the extent of absorption of a drug substance in humans and directly on the measurement of rates of mass transfer across human intestinal membrane.

Alternatively non-human systems capable of predicting drug absorption in humans can be used (such as in-vitro culture methods). A drug substance is considered highly permeable when the extent of absorption in humans is determined to be 85% or more of the administered dose based on a mass-balance determination or in comparison to an intravenous dose.

See also

ADME Partition coefficient Bioavailability Drug metabolism First pass effect Polar surface area IVIVC

BCS guidance of the U.S. Food and Drug Administration ICH M9 Guidance of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Text derived from https://en.wikipedia.org/w/index.php?oldid=1345644329 under CC BY-SA 4.0; modifications have been made.

Words in each sectionDefinitionsDefinitionsDefinitions: 173 words173See alsoSee alsoSee also: 13 words13
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot enwiki-001345644329 · captured 2026-03-27 · ledger · version history

Cite this page as: encyclopegia.org, “Biopharmaceutics Classification System”, snapshot enwiki-001345644329. https://encyclopegia.org/a/biopharmaceutics-classification-system

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.